Qualität der frühzeitigen Sepsisdiagnostik auf deutschen Intensivstationen – Ergebnisse einer bundesweiten Umfrage
摘要
The management of sepsis patients remains an ongoing challenge in intensive care medicine and leads to unacceptably high morbidity and mortality rates, even in medically highly developed countries.
ObjectiveWhat is the state of the quality of early sepsis treatment on German intensive care units (ICUs)?
Material and methodsTo assess the quality of early sepsis treatment, we conducted a nationwide internet-based survey among members of the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI).
ResultsA total of 1935 intensive care physicians across Germany were surveyed of whom 459 experienced specialist physicans responded, including 38% chief physicians and 61% senior physicians. Overall, 66% of participants reported the use of screening tools for early sepsis detection, with the quick-sepsis organ failure assessment (qSOFA) being the most frequently used (71%). In 32.7% of the surveyed ICUs a microbiologist was available around the clock. Interdisciplinary rounds involving a microbiologist or a clinical pharmacologist took place in 55.5% and 52.5% of ICUs, respectively. Molecular diagnostic procedures (e.g., SeptiFast®) for rapid pathogen identification were available in only 10.9% of the surveyed ICUs.
DiscussionIn summary, the use of the qSOFA score remains widespread despite deviating recommendations in current international guidelines. Additionally, interdisciplinary rounds involving microbiology or pharmacology were conducted in only half of the participating ICUs. Molecular biological diagnostic procedures are still not part of the diagnostic standard in most hospitals.
Graphic abstract